Our results suggest that chemogenetic inhibition of TRPV1+ neurons is not sufficient to reduce DSS-induced colitis, whereas CNO stimulation induces neurogenic inflammation in the colon, highlighted by TNF-α, IL-1β, or IL-6 upregulation. The gene discussed is IL6; the disease is colitis.